Pembrolizumab will be given about 24 hours after the T cell infusion by vein over about 30 to 60 minutes. Pembrolizumab takes away the natural immune system process that would stop the CD8+T cells. You will have additional infusions 3, 6, 9, 12, and 15 weeks after the T cell infusion.